242 related articles for article (PubMed ID: 6095882)
21. [In vitro sensitivity of 39 strains of Pseudomonas aeruginosa isolated from urine culture of hospitalized patients].
Vanni M; Zucca C
Minerva Med; 1986 Jun; 77(27):1289-92. PubMed ID: 3088493
[TBL] [Abstract][Full Text] [Related]
22. Serotyping, sites of isolation and resistance of Pseudomonas aeruginosa.
Dette GA; Knothe H; Schäfer V; Pirlet-Berninger U
Microbiologica; 1988 Apr; 11(2):129-35. PubMed ID: 3136301
[TBL] [Abstract][Full Text] [Related]
23. Development of a rapid colorimetric time-kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa.
Moriarty F; Elborn S; Tunney M
J Microbiol Methods; 2005 May; 61(2):171-9. PubMed ID: 15722142
[TBL] [Abstract][Full Text] [Related]
24. Serological and pyocin typing and antibiotic sensitivity of Pseudomonas aeruginosa strains.
Del Piano M; La Palombara P; Picci A; Nicosia R
Microbiologica; 1986 Apr; 9(2):253-8. PubMed ID: 3086671
[TBL] [Abstract][Full Text] [Related]
25. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
26. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
Cluzel M; Chanal M; Sirot J; Cluzel R
Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
28. Comparative susceptibilities of 40 strains of Pseudomonas aeruginosa to 10 antipseudomonal antimicrobial agents.
Davidson S; Lipshitz M; Bogokowski B; Rubinstein E
Isr J Med Sci; 1982 Aug; 18(8):859-62. PubMed ID: 6811501
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of sulperazon against recent isolates of ceftazidime-resistant bacteria.
Lim VK; Halijah MY
Med J Malaysia; 2001 Sep; 56(3):365-9. PubMed ID: 11732084
[TBL] [Abstract][Full Text] [Related]
30. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
31. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
32. [Contribution of Pseudomonas Aeruginosa strains to infections in patients of specialistic outpatients clinics of the SP ZOZ in Nidzica].
Pszenna M; Rokosz A; Luczak M
Med Dosw Mikrobiol; 2005; 57(4):417-24. PubMed ID: 16773835
[TBL] [Abstract][Full Text] [Related]
33. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M
Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of ceftazidime and other beta-lactam antibiotics against nosocomial strains of Pseudomonas aeruginosa.
Santos Ferreira MO; Bacelar MJ; Canica MM
J Int Med Res; 1984; 12(6):356-60. PubMed ID: 6440822
[TBL] [Abstract][Full Text] [Related]
35. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Mintz L; Drew WL
Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
[TBL] [Abstract][Full Text] [Related]
36. [Observations on antibiotic sensitivity of "Pseudomonas aeruginosa" strains isolated in pediatric wards (author's transl)].
D'Antonio D; Aquilano A; Cellini R; Madrigale M; Melena E; Menduni P; Sabatino G; Riario Sforza G; Midulla M
Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():700-3. PubMed ID: 122155
[TBL] [Abstract][Full Text] [Related]
37. [Monotherapy of systematic Pseudomonas aeruginosa infections with ceftazidime. The causes of therapeutic failures].
Blaser J; Bauernfeind A; Vogt M; Lüthy R
Dtsch Med Wochenschr; 1983 Sep; 108(35):1312-7. PubMed ID: 6411442
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD
J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987
[TBL] [Abstract][Full Text] [Related]
39. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Chau PY; Ling J; Ng WS
J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
[TBL] [Abstract][Full Text] [Related]
40. In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamases.
Livermore DM; Williams RJ; Williams JD
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():163-7. PubMed ID: 19802980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
